Publications of Shreemanta K. Parida
All genres
Journal Article (20)
2019
Journal Article
10, 527 (2019)
Immunometabolic Signatures Predict Risk of Progression to Active Tuberculosis and Disease Outcome. Frontiers in immunology 2018
Journal Article
9 (1), 5208 (2018)
Metabolite changes in blood predict the onset of tuberculosis. Nature Communications
Journal Article
197 (9), pp. 1198 - 1208 (2018)
Four-Gene Pan-African Blood Signature Predicts Progression to Tuberculosis. American Journal of Respiratory and Critical Care Medicine 2016
Journal Article
387 (10035), pp. 2312 - 2322 (2016)
A blood RNA signature for tuberculosis disease risk: a prospective cohort study. Lancet 2013
Journal Article
8 (9), e74080 (2013)
Analysis of Host Responses to Mycobacterium tuberculosis Antigens in a Multi-Site Study of Subjects with Different TB and HIV Infection States in Sub-Saharan Africa. PLoS One 2012
Journal Article
7 (7), e40221 (2012)
Biomarkers of Inflammation, Immunosuppression and Stress with Active Disease Are Revealed by Metabolomic Profiling of Tuberculosis Patients. PLoS ONE
Journal Article
7 (6), e38501 (2012)
Potential of Host Markers Produced by Infection Phase-Dependent Antigen-Stimulated Cells for the Diagnosis of Tuberculosis in a Highly Endemic Area. PLoS ONE
Journal Article
12, 10 (2012)
Potential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden setting. BMC Infectious Diseases 2011
Journal Article
12 (1), pp. 15 - 22 (2011)
Human gene expression profiles of susceptibility and resistance in tuberculosis. Genes and Immunity 2010
Journal Article
14 (6 Suppl. Suppl. 1), pp. S3 - S7 (2010)
Closing the gaps in our understanding of the pathogenesis of tuberculosis. International Journal of Tuberculosis and Lung Disease
Journal Article
22 (3), pp. 374 - 384 (2010)
Novel tuberculosis vaccines on the horizon. Current Opinion in Immunology
Journal Article
15 (3-4 Sp. Iss. Sp. Iss. SI), pp. 148 - 157 (2010)
The quest for biomarkers in tuberculosis. Drug Discovery Today
Journal Article
10 (2), pp. 68 - 69 (2010)
Biomarkers for tuberculosis disease activity, cure, and relapse. Lancet Infectious Diseases
Journal Article
11, 27 (2010)
Biomarker discovery in heterogeneous tissue samples -taking the in-silico deconfounding approach. BMC Bioinformatics 2009
Journal Article
16 (8), pp. 1203 - 1212 (2009)
Immunogenicity of Novel DosR Regulon-Encoded Candidate Antigens of Mycobacterium tuberculosis in Three High-Burden Populations in Africa. Clinical and Vaccine Immunology
Journal Article
9 (3), pp. 162 - 172 (2009)
Biomarkers for tuberculosis disease activity, cure, and relapse. Lancet Infectious Diseases 2008
Journal Article
4 (3), pp. 219 - 228 (2008)
Tuberculosis in Africa: Learning from pathogenesis for biomarker identification. Cell Host & Microbe
Journal Article
5 (7), 145, pp. 1033 - 1036 (2008)
Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations. PLoS Medicine 2007
Journal Article
9 (5), pp. 623 - 628 (2007)
Tumor necrosis factor is critical to control tuberculosis infection. Microbes and Infection
Journal Article
13 (3), pp. 299 - 303 (2007)
Changing funding patterns in tuberculosis. Nature Medicine